SlideShare ist ein Scribd-Unternehmen logo
1 von 45
Prof. Aboubakr Elnashar
Benha University Hospital, Egypt
Aboubakr Elnashar
1.2nd trimester miscarriage
2.Ante partum hemorrhage
3.PTL
4.PROM
5.Decreased or absent fetal movements
6.Trauma
Aboubakr Elnashar
Causes:
1.Cervical incompetence
2.Fibroid
3.Uterine malformation
Aboubakr Elnashar
Cervical incompetence
•TVS: only technique used reliably to measure the
cervical length
[TAS: full bladder to visualize the cervix elongates the
cervix
TVS: an empty bladder and no distortion]
Aboubakr Elnashar
1. Cervix length < 25 mm
2. Funneling of int os:
-T, Y, V, U (correlation between the length of the cervix
and the changes in the internal os).
(Trust Your Vaginal Ultrasound)
-in response to pressure on the uterine fundus
-Serial evaluation/2 w
4. Protrusion of the membranes.
5. Fetal parts in the cervix or vagina
Aboubakr Elnashar
Aboubakr Elnashar
History-indicated cerclage (RCOG, 2011)
Indications
Three or more previous PTL and/or 2nd T
miscarriage.
Not an indication:
two or fewer PTL and/or 2nd T miscarriage.
Aboubakr Elnashar
Ultrasound-indicated cerclage (RCOG, 2011)
Indication:
 History of one or more spontaneous 2nd T
miscarriage or PTL
TVS: cervix is 25 mm or less
 Not indicated
No history of spontaneous 2nd T miscarriage or
PTL
Funnelling of the cervix
Aboubakr Elnashar
Cervical cerclage is not recommended (RCOG, 2011)
1. Multiple pregnancies
{±detrimental
increase in 2nd T miscarriage or PTL}.
2. Uterine anomalies
3. Cervical surgery
cone biopsy
LLETZ
destructive procedures (laser ablation or diathermy)
multiple dilatation and evacuation.
Aboubakr Elnashar
Define:
Bleeding from genital tract after fetal viability
Causes:
1.Placenta praevia:
2.Abruptio placentae
3.Vasa praevia
4.Local causes
Aboubakr Elnashar
IV. Complete Centralis III. Complete partial II. Marginalis I. Lateralis
Major Minor
TVS: Distance between lower edge of the placenta & internal os
<2 cm in the third trimester: CS especially if the
placenta is thick (RCOG, 2011)
Placenta praevia
Grading: Now obsolete in clinical practice
Aboubakr Elnashar
US:
diagnose placenta praevia
(RCOG,2011)
TVS
safe in the presence of PP
more accurate than TAS in locating the placenta
(RCOG , 2005 ).
Aboubakr Elnashar
Placental abruption
Retroplacental Marginal
Subamniotic, intraplacental
Aboubakr Elnashar
US: (RCOG, 2011)
does not exclude abruption.
{Placental abruption is a clinical diagnosis
sensitivity is poor}
Sensitivity: 24%: fail to detect three-quarters of cases
Specificity: 96%: When suggests an abruption, the
likelihood that there is an abruption is high.
Fetal heart pulsation if fetal viability cannot be
detected using external auscultation.
Aboubakr Elnashar
 Regular contractions with cervical change before
37w
(ACOG, 2003)
1. Prediction
2. Management
Aboubakr Elnashar
I. Prediction:
TVS is more accurate than digital examination
[Provides reliable length, dilation, funneling]
High NPV: 89% if > 2.5 cm
Risk PTD  with cervix length 
Accepted safe length is 3 cm
Cx length > 3cm: No risk of PTL
Cx length <2cm: 70% will deliver PT
Recommended
high risk/symptomatic patients
Not for routine screening
Aboubakr Elnashar
Length of the endocervix can be measured
using TVS
Aboubakr Elnashar
Antenatal corticosteroids (RCOG, 2010)
Single course of to women between 24+0 and
34+6W who are at risk of PTL.
should be given to all women for whom an elective
CS is planned prior to 38+6 w.
Elective CS should be performed at or after 39+0
w to reduce respiratory morbidity.
Aboubakr Elnashar
II. Management:
1. Presentation
2. Fetal weight
Shepard:
BPD & AC
Accurate within 10-15 %
Hadlock:
FL & AC
3. Fetal wellbeing in high risk pregnancies,
Aboubakr Elnashar
Tocolytic drugs: RCOG, 2011
Nifedipine and atosiban oxytocin receptor agonist have
comparable effectiveness in delaying birth for up to
seven days.
Compared with beta-agonists, nifedipine is
associated with improvement in neonatal outcome.
Nifedipine: initial oral dose of 20 mg followed by 10–
20 mg three to four times daily, adjusted according to
uterine activity for up to 48 h.
Aboubakr Elnashar
Define:
Leakage of AF in absence of uterine activity
Latency: The interval between ROM & onset of
contractions
Types:
PretermPROM
TermPROM
Aboubakr Elnashar
Management:
useful: history PROM but negative speculum exam.
 Cervix length, gestational age
•AFV
correlate with:
latency in PPROM
neonatal morbidity & mortality in 2nd PROM
•FBP:
reduced in chorioamnionitis.
sensitivity: 25%
Aboubakr Elnashar
PPROMP (RCOG,2010)
Observe for signs of clinical chorioamnionitis.
Not necessary: Weekly high vaginal swab
weekly CBC or CRP {sensitivity is low}.
CTG is useful: fetal tachycardia: cl chorioamnionitis.
FBP and Doppler: limited value in predicting fetal
infection.
Antenatal corticosteroids should be administered
Delivery should be considered at 34 w
Aboubakr Elnashar
I. Living
II. Fetal wellbeing
1. Foetal growth assessment
2. FBP
3. Doppler
Aboubakr Elnashar
1. Fetal growth assessment
US/2w: HC and AC.
AC
most sensitive predictor of fetal growth.
increases 2cm/2w after 24 w in the average fetus.
measurements are plotted on centile charts.
fall in the growth velocity of AC indicates IUGR.
AC used to assess fetal growth
Aboubakr Elnashar
Aboubakr Elnashar
Score 2 Score 0
CTG >2 accelrations/40
min
<
F. movements >3/30 min <
F.breathing.
movements (FBM)
30 sec sustained
FBM/30 min
<
F.tone closed fist or
flexion to
extension
movement
Neither
Am Fluid
Volume
>1 cm pocket <
2. BPP
Aboubakr Elnashar
3. Doppler
more useful test of fetal wellbeing than CTG or FBP.
Umbilical arterial blood flow
Middle cerebral artery
Aboubakr Elnashar
a. Umbilical artery Doppler
Idea:
Umbilical Arterial Flow is normally low resistance.
In hypoxic states:
relative placental hypoxia:
reactive VC of umbilical artery tributaries:
higher resistance:
relative decrease in diastolic flow
Aboubakr Elnashar
Doppler indices
Aboubakr Elnashar
•Resistance index:
Best ability to predict abnormal outcomes
(RCOG,2002 Evidence level II)
 Normal pregnancy:
{progressive increase in end-diastolic velocity
{growth& dilatation of the umbilical circulation}:
Resistance index falls.
Fetal growth restriction and/or PET:
> 0.72 is outside the normal limits from 26 w.
Aboubakr Elnashar
•S/D should be <3.
small increases in S/D= 3-5: chronic intrauterine
disease manifest by IUGR.
Not strictly useful:
{1. low sensitivity.
2. Gestation age dependent}.
•Diastolic flow is absent {AED}or reversed (RED}
Fetal distress is almost certain:
Immediate BPP or NST or
Delivery may be indicated.
Aboubakr Elnashar
Normal
Absent
Reversed
Aboubakr Elnashar
b. Middle cerebral artery peak systolic velocity (MCA-
PSV)
The most significant breakthrough in the surveillance of
the potentially anemic fetus
Based on:
In fetal anemia:
Enhanced fetal cardiac output and
Decrease in blood viscosity:
Increased blood flow velocity
preferentially shunt blood to brain faster
most pronounced MCA PSV
Aboubakr Elnashar
Frequency
•Initiated: 18 w
•Repeated: every 1–2 w as the clinical situation
MCA waveforms in an anemic fetus
requiring serial transfusions for severe Rh
(D) disease.
The peak systolic velocities of 62, 50, and
61 cm per second (top to bottom)
corresponded to fetal hematocrits of 19%,
44%, and 32%, before, at the time of, and a
week after the first intravascular
transfusion, respectively.
Aboubakr Elnashar
Aboubakr Elnashar
Advantage
More sensitive for predicting f anemia than the
ΔOD450 (Recent studies)
Alternative to serial amniocenteses
Excellent noninvasive tool for the monitoring of f
anemia.
Aboubakr Elnashar
Reduced Foetal movements (RCOG, 20011)
1. History
Risk factors for stillbirth and FGR.
Sudden change in fetal activity
2. Auscultate the fetal heart
Doppler device to exclude fetal death.
3. CTG
{exclude fetal compromise}
Aboubakr Elnashar
4. US
RFM persists despite a normal CTG
risk factors for FGR/stillbirth.
 AC
EFW {detect the SGA}
AFV
Doppler
Fetal morphology
Aboubakr Elnashar
5. ± BPP:
± a role in high risk pregnancies:
Systematic review of RCT:
does not support its use as a test of fetal wellbeing
Uncontrolled observational studies:
BBP has good NPV
Fetal death is rare with normal BPP.
Aboubakr Elnashar
Mother:
•Noninvasive
•Does not require transport of the mother out of the
ED.
•Detects free intraperitoneal fluid or hemorrhage
•FAST: The focused assessment with sonography for
trauma
routine in many trauma centers
high sensitivity and accuracy
Aboubakr Elnashar
Fetus:
•Safe
•Assess viability.
multiple gestations.
size, gestational age, and position of the fetus.
Aboubakr Elnashar
Indications of cerclage:
1. Three or more PTL and/or 2nd T miscarriage.
2. History of one or more spontaneous 2nd T
miscarriage or PTL and TVS: cervix is 25 mm or
less
Cervical cerclage is not recommended: multiple
pregnancies, uterine anomalies, cervical surgery
CS if placenta <2 cm from internal os in the 3rd T
Antenatal corticosteroids if elective CS is planned
prior to 38+6 w.
Aboubakr Elnashar
 Umbilical a Doppler:
• RI >0.72 is outside the normal limits from 26 w.
• S/D >3.
• Diastolic flow is absent or reversed: Fetal distress
is almost certain: Immediate BPP or NST or delivery
 Middle cerebral artery peak systolic velocity: most
significant breakthrough in the surveillance of the
potentially anemic fetus
Aboubakr Elnashar
Thanks
elnashar53@hotmail.com
Aboubakr Elnashar

Weitere ähnliche Inhalte

Was ist angesagt?

PREGNANCY OUTCOMES AFTER ART
PREGNANCY OUTCOMES AFTER ARTPREGNANCY OUTCOMES AFTER ART
PREGNANCY OUTCOMES AFTER ARTAboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021Aboubakr Elnashar
 
Chorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityChorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityAli Al-Shimmary
 
Preterm labour
Preterm labourPreterm labour
Preterm labourdrmcbansal
 
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCY
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCYMEDICAL MANAGEMENT OF NON-VIABLE PREGNANCY
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCYAboubakr Elnashar
 
Pprom ho presentation
Pprom ho presentationPprom ho presentation
Pprom ho presentationlimgengyan
 
Multiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharMultiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharAboubakr Elnashar
 
Preterm prelabour rupture of membranes (P-PROM) NICE guideline November 2015
Preterm prelabour rupture of membranes  (P-PROM) NICE guideline November 2015Preterm prelabour rupture of membranes  (P-PROM) NICE guideline November 2015
Preterm prelabour rupture of membranes (P-PROM) NICE guideline November 2015Aboubakr Elnashar
 
Bleeding in early pregnancy
Bleeding in early pregnancy Bleeding in early pregnancy
Bleeding in early pregnancy Aboubakr Elnashar
 
Premature Labour
Premature LabourPremature Labour
Premature Labourlimgengyan
 
Premature Rupture Of Membranes
Premature Rupture Of MembranesPremature Rupture Of Membranes
Premature Rupture Of Membranesguest8b10e7
 
preterm and postterm labour
 preterm and postterm labour preterm and postterm labour
preterm and postterm labourZeeshan Khan
 
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...alka mukherjee
 
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR Lifecare Centre
 

Was ist angesagt? (19)

PREGNANCY OUTCOMES AFTER ART
PREGNANCY OUTCOMES AFTER ARTPREGNANCY OUTCOMES AFTER ART
PREGNANCY OUTCOMES AFTER ART
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 
Chorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain UniversityChorioamnionitis and PROM - Nahrain University
Chorioamnionitis and PROM - Nahrain University
 
Preterm
PretermPreterm
Preterm
 
Covid19 &amp; pregnancy
Covid19 &amp; pregnancyCovid19 &amp; pregnancy
Covid19 &amp; pregnancy
 
Preterm labor
Preterm laborPreterm labor
Preterm labor
 
Preterm labour
Preterm labourPreterm labour
Preterm labour
 
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCY
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCYMEDICAL MANAGEMENT OF NON-VIABLE PREGNANCY
MEDICAL MANAGEMENT OF NON-VIABLE PREGNANCY
 
Preterm labor
Preterm laborPreterm labor
Preterm labor
 
Pprom ho presentation
Pprom ho presentationPprom ho presentation
Pprom ho presentation
 
Multiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr ElnasharMultiple pregnancy: Aboubakr Elnashar
Multiple pregnancy: Aboubakr Elnashar
 
Preterm prelabour rupture of membranes (P-PROM) NICE guideline November 2015
Preterm prelabour rupture of membranes  (P-PROM) NICE guideline November 2015Preterm prelabour rupture of membranes  (P-PROM) NICE guideline November 2015
Preterm prelabour rupture of membranes (P-PROM) NICE guideline November 2015
 
Bleeding in early pregnancy
Bleeding in early pregnancy Bleeding in early pregnancy
Bleeding in early pregnancy
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
Premature Labour
Premature LabourPremature Labour
Premature Labour
 
Premature Rupture Of Membranes
Premature Rupture Of MembranesPremature Rupture Of Membranes
Premature Rupture Of Membranes
 
preterm and postterm labour
 preterm and postterm labour preterm and postterm labour
preterm and postterm labour
 
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...
Preterm birth & role of progesterone by dr alka mukherjee dr apurva mukherjee...
 
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
MANAGEMENT OF PRETERM PROM ON INDUCTION OF LABOUR
 

Andere mochten auch

Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...Aboubakr Elnashar
 
Prediction of pregnancy outcome after ICSI
Prediction  of pregnancy outcome  after ICSIPrediction  of pregnancy outcome  after ICSI
Prediction of pregnancy outcome after ICSIAboubakr Elnashar
 
Acute fatty liver of pregnancy
Acute fatty liver of pregnancyAcute fatty liver of pregnancy
Acute fatty liver of pregnancyAboubakr Elnashar
 
Management of Overactive Bladder For Gynecologist
Management of Overactive BladderFor GynecologistManagement of Overactive BladderFor Gynecologist
Management of Overactive Bladder For GynecologistAboubakr Elnashar
 
PREGNANCY OF UNKNOWN LOCATION
PREGNANCY OF UNKNOWN LOCATIONPREGNANCY OF UNKNOWN LOCATION
PREGNANCY OF UNKNOWN LOCATIONAboubakr Elnashar
 
Management of first trimester miscarriage
Management of first trimester miscarriageManagement of first trimester miscarriage
Management of first trimester miscarriageAboubakr Elnashar
 
Chronic Pelvic Pain in Women: An Evidence based approach
Chronic Pelvic Pain in Women: An Evidence based approach Chronic Pelvic Pain in Women: An Evidence based approach
Chronic Pelvic Pain in Women: An Evidence based approach Aboubakr Elnashar
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharAboubakr Elnashar
 
Hormonal assay in clinical gynecology
Hormonal assay  in clinical gynecologyHormonal assay  in clinical gynecology
Hormonal assay in clinical gynecologyAboubakr Elnashar
 
Some important questions in obstetrics and gynecology
Some important questions in obstetrics and gynecologySome important questions in obstetrics and gynecology
Some important questions in obstetrics and gynecologyAboubakr Elnashar
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success Aboubakr Elnashar
 
Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Aboubakr Elnashar
 
Miscellanous colposcopic findings
Miscellanous  colposcopic findingsMiscellanous  colposcopic findings
Miscellanous colposcopic findingsAboubakr Elnashar
 
HOW to be an Evidence Based practitioner in an easy way?
HOW to be an Evidence Based practitioner in an easy way?HOW to be an Evidence Based practitioner in an easy way?
HOW to be an Evidence Based practitioner in an easy way?Aboubakr Elnashar
 

Andere mochten auch (20)

Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...Prediction of pregnancy outcome and multiple gestation by measurement of seru...
Prediction of pregnancy outcome and multiple gestation by measurement of seru...
 
Prediction of pregnancy outcome after ICSI
Prediction  of pregnancy outcome  after ICSIPrediction  of pregnancy outcome  after ICSI
Prediction of pregnancy outcome after ICSI
 
Acute fatty liver of pregnancy
Acute fatty liver of pregnancyAcute fatty liver of pregnancy
Acute fatty liver of pregnancy
 
Management of Overactive Bladder For Gynecologist
Management of Overactive BladderFor GynecologistManagement of Overactive BladderFor Gynecologist
Management of Overactive Bladder For Gynecologist
 
Bacterial vaginosis
Bacterial vaginosisBacterial vaginosis
Bacterial vaginosis
 
Fibroid and infertility
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
 
PREGNANCY OF UNKNOWN LOCATION
PREGNANCY OF UNKNOWN LOCATIONPREGNANCY OF UNKNOWN LOCATION
PREGNANCY OF UNKNOWN LOCATION
 
Management of first trimester miscarriage
Management of first trimester miscarriageManagement of first trimester miscarriage
Management of first trimester miscarriage
 
Chronic Pelvic Pain in Women: An Evidence based approach
Chronic Pelvic Pain in Women: An Evidence based approach Chronic Pelvic Pain in Women: An Evidence based approach
Chronic Pelvic Pain in Women: An Evidence based approach
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
 
Hormonal assay in clinical gynecology
Hormonal assay  in clinical gynecologyHormonal assay  in clinical gynecology
Hormonal assay in clinical gynecology
 
Some important questions in obstetrics and gynecology
Some important questions in obstetrics and gynecologySome important questions in obstetrics and gynecology
Some important questions in obstetrics and gynecology
 
ART: Factors affecting success
ART:  Factors affecting  success ART:  Factors affecting  success
ART: Factors affecting success
 
Management of Fetal hydrocephalus
Management of Fetal hydrocephalus Management of Fetal hydrocephalus
Management of Fetal hydrocephalus
 
Ovarian Factor Infertility
Ovarian Factor InfertilityOvarian Factor Infertility
Ovarian Factor Infertility
 
Endometrial carcinoma
Endometrial carcinomaEndometrial carcinoma
Endometrial carcinoma
 
PREMARITAL COUNSELING
PREMARITAL COUNSELINGPREMARITAL COUNSELING
PREMARITAL COUNSELING
 
Implantation
ImplantationImplantation
Implantation
 
Miscellanous colposcopic findings
Miscellanous  colposcopic findingsMiscellanous  colposcopic findings
Miscellanous colposcopic findings
 
HOW to be an Evidence Based practitioner in an easy way?
HOW to be an Evidence Based practitioner in an easy way?HOW to be an Evidence Based practitioner in an easy way?
HOW to be an Evidence Based practitioner in an easy way?
 

Ähnlich wie Emergency ultrasonography in 2nd 3rd timester

invasive procedures for prenatal diagnosis ISUOG Guidelines
invasive procedures for prenatal diagnosis ISUOG Guidelines invasive procedures for prenatal diagnosis ISUOG Guidelines
invasive procedures for prenatal diagnosis ISUOG Guidelines Aboubakr Elnashar
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringrajeev sood
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr ElnasharAboubakr Elnashar
 
Foetal Monitoring
Foetal MonitoringFoetal Monitoring
Foetal MonitoringMohd Hanafi
 
Principle of fetal monitoring
Principle of fetal monitoringPrinciple of fetal monitoring
Principle of fetal monitoringDr. Rubz
 
Management of Thromboembolic Disease in Pregnancy and Puerperium
Management of Thromboembolic Disease  in Pregnancy and  PuerperiumManagement of Thromboembolic Disease  in Pregnancy and  Puerperium
Management of Thromboembolic Disease in Pregnancy and PuerperiumAboubakr Elnashar
 
Fetal surveillance
Fetal surveillanceFetal surveillance
Fetal surveillancemaricar chua
 
The 10 recommendations of society for maternal fetal medicine" AN Testing
The 10 recommendations of society for maternal fetal medicine" AN TestingThe 10 recommendations of society for maternal fetal medicine" AN Testing
The 10 recommendations of society for maternal fetal medicine" AN TestingAboubakr Elnashar
 
radiology & imaging in OB/GYN
radiology & imaging in OB/GYNradiology & imaging in OB/GYN
radiology & imaging in OB/GYNtariggally
 
Antepartum fetal surveillance .pptx
Antepartum fetal surveillance .pptxAntepartum fetal surveillance .pptx
Antepartum fetal surveillance .pptxAbisharthiniDurai1
 
approach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceapproach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceDr Praman Kushwah
 
Management of monochorionic pregnancy
Management of monochorionic pregnancy Management of monochorionic pregnancy
Management of monochorionic pregnancy PoojaNagappa
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing Dr Praman Kushwah
 
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINE
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINETREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINE
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINEAboubakr Elnashar
 

Ähnlich wie Emergency ultrasonography in 2nd 3rd timester (20)

invasive procedures for prenatal diagnosis ISUOG Guidelines
invasive procedures for prenatal diagnosis ISUOG Guidelines invasive procedures for prenatal diagnosis ISUOG Guidelines
invasive procedures for prenatal diagnosis ISUOG Guidelines
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
 
Prom
PromProm
Prom
 
Postdate pregnancy
Postdate pregnancyPostdate pregnancy
Postdate pregnancy
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
 
FIRST TRIMESTER BLEEDING
FIRST TRIMESTER BLEEDINGFIRST TRIMESTER BLEEDING
FIRST TRIMESTER BLEEDING
 
Breech presentation
Breech presentation Breech presentation
Breech presentation
 
Foetal Monitoring
Foetal MonitoringFoetal Monitoring
Foetal Monitoring
 
Principle of fetal monitoring
Principle of fetal monitoringPrinciple of fetal monitoring
Principle of fetal monitoring
 
Management of Thromboembolic Disease in Pregnancy and Puerperium
Management of Thromboembolic Disease  in Pregnancy and  PuerperiumManagement of Thromboembolic Disease  in Pregnancy and  Puerperium
Management of Thromboembolic Disease in Pregnancy and Puerperium
 
Fetal surveillance
Fetal surveillanceFetal surveillance
Fetal surveillance
 
Bleeding during early pregnancy
Bleeding during early pregnancyBleeding during early pregnancy
Bleeding during early pregnancy
 
The 10 recommendations of society for maternal fetal medicine" AN Testing
The 10 recommendations of society for maternal fetal medicine" AN TestingThe 10 recommendations of society for maternal fetal medicine" AN Testing
The 10 recommendations of society for maternal fetal medicine" AN Testing
 
radiology & imaging in OB/GYN
radiology & imaging in OB/GYNradiology & imaging in OB/GYN
radiology & imaging in OB/GYN
 
Antepartum fetal surveillance .pptx
Antepartum fetal surveillance .pptxAntepartum fetal surveillance .pptx
Antepartum fetal surveillance .pptx
 
approach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceapproach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survelliance
 
Management of monochorionic pregnancy
Management of monochorionic pregnancy Management of monochorionic pregnancy
Management of monochorionic pregnancy
 
Thin Endometrium
Thin EndometriumThin Endometrium
Thin Endometrium
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing
 
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINE
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINETREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINE
TREATMENT GUIDELINES OF SOCIETY OF MATERNAL AND FETAL MEDICINE
 

Mehr von Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTAboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertilityAboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversyAboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gynAboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineAboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationAboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021 Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown locationAboubakr Elnashar
 

Mehr von Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
 
update on PCOS
update on PCOSupdate on PCOS
update on PCOS
 

Kürzlich hochgeladen

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 

Kürzlich hochgeladen (20)

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 

Emergency ultrasonography in 2nd 3rd timester

  • 1. Prof. Aboubakr Elnashar Benha University Hospital, Egypt Aboubakr Elnashar
  • 2. 1.2nd trimester miscarriage 2.Ante partum hemorrhage 3.PTL 4.PROM 5.Decreased or absent fetal movements 6.Trauma Aboubakr Elnashar
  • 4. Cervical incompetence •TVS: only technique used reliably to measure the cervical length [TAS: full bladder to visualize the cervix elongates the cervix TVS: an empty bladder and no distortion] Aboubakr Elnashar
  • 5. 1. Cervix length < 25 mm 2. Funneling of int os: -T, Y, V, U (correlation between the length of the cervix and the changes in the internal os). (Trust Your Vaginal Ultrasound) -in response to pressure on the uterine fundus -Serial evaluation/2 w 4. Protrusion of the membranes. 5. Fetal parts in the cervix or vagina Aboubakr Elnashar
  • 7. History-indicated cerclage (RCOG, 2011) Indications Three or more previous PTL and/or 2nd T miscarriage. Not an indication: two or fewer PTL and/or 2nd T miscarriage. Aboubakr Elnashar
  • 8. Ultrasound-indicated cerclage (RCOG, 2011) Indication:  History of one or more spontaneous 2nd T miscarriage or PTL TVS: cervix is 25 mm or less  Not indicated No history of spontaneous 2nd T miscarriage or PTL Funnelling of the cervix Aboubakr Elnashar
  • 9. Cervical cerclage is not recommended (RCOG, 2011) 1. Multiple pregnancies {±detrimental increase in 2nd T miscarriage or PTL}. 2. Uterine anomalies 3. Cervical surgery cone biopsy LLETZ destructive procedures (laser ablation or diathermy) multiple dilatation and evacuation. Aboubakr Elnashar
  • 10. Define: Bleeding from genital tract after fetal viability Causes: 1.Placenta praevia: 2.Abruptio placentae 3.Vasa praevia 4.Local causes Aboubakr Elnashar
  • 11. IV. Complete Centralis III. Complete partial II. Marginalis I. Lateralis Major Minor TVS: Distance between lower edge of the placenta & internal os <2 cm in the third trimester: CS especially if the placenta is thick (RCOG, 2011) Placenta praevia Grading: Now obsolete in clinical practice Aboubakr Elnashar
  • 12. US: diagnose placenta praevia (RCOG,2011) TVS safe in the presence of PP more accurate than TAS in locating the placenta (RCOG , 2005 ). Aboubakr Elnashar
  • 14. US: (RCOG, 2011) does not exclude abruption. {Placental abruption is a clinical diagnosis sensitivity is poor} Sensitivity: 24%: fail to detect three-quarters of cases Specificity: 96%: When suggests an abruption, the likelihood that there is an abruption is high. Fetal heart pulsation if fetal viability cannot be detected using external auscultation. Aboubakr Elnashar
  • 15.  Regular contractions with cervical change before 37w (ACOG, 2003) 1. Prediction 2. Management Aboubakr Elnashar
  • 16. I. Prediction: TVS is more accurate than digital examination [Provides reliable length, dilation, funneling] High NPV: 89% if > 2.5 cm Risk PTD  with cervix length  Accepted safe length is 3 cm Cx length > 3cm: No risk of PTL Cx length <2cm: 70% will deliver PT Recommended high risk/symptomatic patients Not for routine screening Aboubakr Elnashar
  • 17. Length of the endocervix can be measured using TVS Aboubakr Elnashar
  • 18. Antenatal corticosteroids (RCOG, 2010) Single course of to women between 24+0 and 34+6W who are at risk of PTL. should be given to all women for whom an elective CS is planned prior to 38+6 w. Elective CS should be performed at or after 39+0 w to reduce respiratory morbidity. Aboubakr Elnashar
  • 19. II. Management: 1. Presentation 2. Fetal weight Shepard: BPD & AC Accurate within 10-15 % Hadlock: FL & AC 3. Fetal wellbeing in high risk pregnancies, Aboubakr Elnashar
  • 20. Tocolytic drugs: RCOG, 2011 Nifedipine and atosiban oxytocin receptor agonist have comparable effectiveness in delaying birth for up to seven days. Compared with beta-agonists, nifedipine is associated with improvement in neonatal outcome. Nifedipine: initial oral dose of 20 mg followed by 10– 20 mg three to four times daily, adjusted according to uterine activity for up to 48 h. Aboubakr Elnashar
  • 21. Define: Leakage of AF in absence of uterine activity Latency: The interval between ROM & onset of contractions Types: PretermPROM TermPROM Aboubakr Elnashar
  • 22. Management: useful: history PROM but negative speculum exam.  Cervix length, gestational age •AFV correlate with: latency in PPROM neonatal morbidity & mortality in 2nd PROM •FBP: reduced in chorioamnionitis. sensitivity: 25% Aboubakr Elnashar
  • 23. PPROMP (RCOG,2010) Observe for signs of clinical chorioamnionitis. Not necessary: Weekly high vaginal swab weekly CBC or CRP {sensitivity is low}. CTG is useful: fetal tachycardia: cl chorioamnionitis. FBP and Doppler: limited value in predicting fetal infection. Antenatal corticosteroids should be administered Delivery should be considered at 34 w Aboubakr Elnashar
  • 24. I. Living II. Fetal wellbeing 1. Foetal growth assessment 2. FBP 3. Doppler Aboubakr Elnashar
  • 25. 1. Fetal growth assessment US/2w: HC and AC. AC most sensitive predictor of fetal growth. increases 2cm/2w after 24 w in the average fetus. measurements are plotted on centile charts. fall in the growth velocity of AC indicates IUGR. AC used to assess fetal growth Aboubakr Elnashar
  • 27. Score 2 Score 0 CTG >2 accelrations/40 min < F. movements >3/30 min < F.breathing. movements (FBM) 30 sec sustained FBM/30 min < F.tone closed fist or flexion to extension movement Neither Am Fluid Volume >1 cm pocket < 2. BPP Aboubakr Elnashar
  • 28. 3. Doppler more useful test of fetal wellbeing than CTG or FBP. Umbilical arterial blood flow Middle cerebral artery Aboubakr Elnashar
  • 29. a. Umbilical artery Doppler Idea: Umbilical Arterial Flow is normally low resistance. In hypoxic states: relative placental hypoxia: reactive VC of umbilical artery tributaries: higher resistance: relative decrease in diastolic flow Aboubakr Elnashar
  • 31. •Resistance index: Best ability to predict abnormal outcomes (RCOG,2002 Evidence level II)  Normal pregnancy: {progressive increase in end-diastolic velocity {growth& dilatation of the umbilical circulation}: Resistance index falls. Fetal growth restriction and/or PET: > 0.72 is outside the normal limits from 26 w. Aboubakr Elnashar
  • 32. •S/D should be <3. small increases in S/D= 3-5: chronic intrauterine disease manifest by IUGR. Not strictly useful: {1. low sensitivity. 2. Gestation age dependent}. •Diastolic flow is absent {AED}or reversed (RED} Fetal distress is almost certain: Immediate BPP or NST or Delivery may be indicated. Aboubakr Elnashar
  • 34. b. Middle cerebral artery peak systolic velocity (MCA- PSV) The most significant breakthrough in the surveillance of the potentially anemic fetus Based on: In fetal anemia: Enhanced fetal cardiac output and Decrease in blood viscosity: Increased blood flow velocity preferentially shunt blood to brain faster most pronounced MCA PSV Aboubakr Elnashar
  • 35. Frequency •Initiated: 18 w •Repeated: every 1–2 w as the clinical situation MCA waveforms in an anemic fetus requiring serial transfusions for severe Rh (D) disease. The peak systolic velocities of 62, 50, and 61 cm per second (top to bottom) corresponded to fetal hematocrits of 19%, 44%, and 32%, before, at the time of, and a week after the first intravascular transfusion, respectively. Aboubakr Elnashar
  • 37. Advantage More sensitive for predicting f anemia than the ΔOD450 (Recent studies) Alternative to serial amniocenteses Excellent noninvasive tool for the monitoring of f anemia. Aboubakr Elnashar
  • 38. Reduced Foetal movements (RCOG, 20011) 1. History Risk factors for stillbirth and FGR. Sudden change in fetal activity 2. Auscultate the fetal heart Doppler device to exclude fetal death. 3. CTG {exclude fetal compromise} Aboubakr Elnashar
  • 39. 4. US RFM persists despite a normal CTG risk factors for FGR/stillbirth.  AC EFW {detect the SGA} AFV Doppler Fetal morphology Aboubakr Elnashar
  • 40. 5. ± BPP: ± a role in high risk pregnancies: Systematic review of RCT: does not support its use as a test of fetal wellbeing Uncontrolled observational studies: BBP has good NPV Fetal death is rare with normal BPP. Aboubakr Elnashar
  • 41. Mother: •Noninvasive •Does not require transport of the mother out of the ED. •Detects free intraperitoneal fluid or hemorrhage •FAST: The focused assessment with sonography for trauma routine in many trauma centers high sensitivity and accuracy Aboubakr Elnashar
  • 42. Fetus: •Safe •Assess viability. multiple gestations. size, gestational age, and position of the fetus. Aboubakr Elnashar
  • 43. Indications of cerclage: 1. Three or more PTL and/or 2nd T miscarriage. 2. History of one or more spontaneous 2nd T miscarriage or PTL and TVS: cervix is 25 mm or less Cervical cerclage is not recommended: multiple pregnancies, uterine anomalies, cervical surgery CS if placenta <2 cm from internal os in the 3rd T Antenatal corticosteroids if elective CS is planned prior to 38+6 w. Aboubakr Elnashar
  • 44.  Umbilical a Doppler: • RI >0.72 is outside the normal limits from 26 w. • S/D >3. • Diastolic flow is absent or reversed: Fetal distress is almost certain: Immediate BPP or NST or delivery  Middle cerebral artery peak systolic velocity: most significant breakthrough in the surveillance of the potentially anemic fetus Aboubakr Elnashar